IT1200603B - Composizione farmaceutiche ad attivita dopaminergica - Google Patents

Composizione farmaceutiche ad attivita dopaminergica

Info

Publication number
IT1200603B
IT1200603B IT20234/85A IT2023485A IT1200603B IT 1200603 B IT1200603 B IT 1200603B IT 20234/85 A IT20234/85 A IT 20234/85A IT 2023485 A IT2023485 A IT 2023485A IT 1200603 B IT1200603 B IT 1200603B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
dopaminergic activity
dopaminergic
activity
pharmaceutical
Prior art date
Application number
IT20234/85A
Other languages
English (en)
Italian (it)
Other versions
IT8520234A0 (it
Inventor
Stefano Poli
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to IT20234/85A priority Critical patent/IT1200603B/it
Publication of IT8520234A0 publication Critical patent/IT8520234A0/it
Priority to DE19853525390 priority patent/DE3525390A1/de
Priority to GB8607848A priority patent/GB2173101B/en
Priority to US06/847,395 priority patent/US4673681A/en
Priority to JP61077528A priority patent/JPS61257922A/ja
Priority to FR868604772A priority patent/FR2579893B1/fr
Application granted granted Critical
Publication of IT1200603B publication Critical patent/IT1200603B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IT20234/85A 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica IT1200603B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica
DE19853525390 DE3525390A1 (de) 1985-04-04 1985-07-16 Verwendung von (alpha)-dihydroergokryptin zur behandlung des parkinson-syndroms, von depressionen und zephalalgien
GB8607848A GB2173101B (en) 1985-04-04 1986-03-27 Dopaminergic compositions containing dihydroergocryptine
US06/847,395 US4673681A (en) 1985-04-04 1986-04-02 Pharmaceutical methods having dopaminergic activity
JP61077528A JPS61257922A (ja) 1985-04-04 1986-04-03 医薬組成物
FR868604772A FR2579893B1 (enEXAMPLES) 1985-04-04 1986-04-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica

Publications (2)

Publication Number Publication Date
IT8520234A0 IT8520234A0 (it) 1985-04-04
IT1200603B true IT1200603B (it) 1989-01-27

Family

ID=11164998

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica

Country Status (6)

Country Link
US (1) US4673681A (enEXAMPLES)
JP (1) JPS61257922A (enEXAMPLES)
DE (1) DE3525390A1 (enEXAMPLES)
FR (1) FR2579893B1 (enEXAMPLES)
GB (1) GB2173101B (enEXAMPLES)
IT (1) IT1200603B (enEXAMPLES)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245369B (it) * 1991-03-28 1994-09-20 Poli Ind Chimica Spa Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
ITMI20041855A1 (it) * 2004-09-29 2004-12-29 Polichem Sa Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
NL7314066A (enEXAMPLES) * 1972-10-18 1974-04-22
DE3043210A1 (de) * 1979-11-27 1981-08-27 Sandoz-Patent-GmbH, 7850 Lörrach Ergolinderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und ihre anwendung bei der therapeutischen behandlung

Also Published As

Publication number Publication date
GB2173101B (en) 1989-09-20
DE3525390A1 (de) 1986-10-09
JPH0415767B2 (enEXAMPLES) 1992-03-19
DE3525390C2 (enEXAMPLES) 1988-07-28
GB8607848D0 (en) 1986-04-30
FR2579893B1 (enEXAMPLES) 1991-07-05
GB2173101A (en) 1986-10-08
JPS61257922A (ja) 1986-11-15
FR2579893A1 (enEXAMPLES) 1986-10-10
US4673681A (en) 1987-06-16
IT8520234A0 (it) 1985-04-04

Similar Documents

Publication Publication Date Title
IT8621358A1 (it) Composizione farmaceutica ad attività analgesica
MX9203170A (es) Composicion farmaceutica con actividad analgesica.
FI862479L (fi) Oral farmaceutisk komposition.
DK546886D0 (da) Farmaceutisk praeparat
DK88186D0 (da) Benzoylurinstofderivater med antitumoraktivitet
BR8602795A (pt) Mancal hidrodinamico
BR8606912A (pt) Conjunto de mancais
DK495586A (da) Piperazinoisothiazoloner med psykotrop aktivitet
IT1187756B (it) Isoindolinil-alchil-piperazine ad attivita' farmaceutica
IT1197061B (it) Composizioni farmaceutiche ad azione vasodilatatrice e antianossica
IT1213453B (it) Composizione farmaceutica.
IT1200603B (it) Composizione farmaceutiche ad attivita dopaminergica
IT1200467B (it) Formulazione farmaceutica
DK492386D0 (da) Bicycliske imider med psykotrop aktivitet
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK499986A (da) Farmaceutisk praeparat med antibakteriel virkning
IT1186772B (it) Composto ad attivita' pilostimolante
IT1190383B (it) Sostanze peptidominetiche ad azione ipotensiva
IT8522705A0 (it) Azolilderivati ad attivita'antufungina.
DE3667915D1 (de) Pharmazeutische zusammensetzung.
BR6500407U (pt) Composicao medicinal
IT8520272A0 (it) Composizione farmaceutica.
RO89429A2 (ro) Compozitie medicamentoasa cu sectiune antialergica
ES291827Y (es) Cojinete perfeccionado
IT8503339A0 (it) Derivati arildiidropiridini ad attivita' calcio-antagonista

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 3

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 3, 19911211; POLI INDUSTRIA CHIMICA S.P.A.(1)

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329